Connect with us

Health

NAFDAC meets manufacturers, frowns at marketing of breast-milk substitutes

Published

on

…Says substitute undermining health of babies

The National Agency for Food and Drug Administration and Control (NAFDAC) has met with the Association of Infant Food Manufacturers and Marketers in Nigeria (AIFMN) on the implementation of the International Code of Marketing of Breastmilk Substitutes noting that the marketing of breast-milk substitutes is undermining the health of babies.

Speaking at an interaction with the stakeholders, Director General of NAFDAC, Prof. Mojisola Adeyeye who was represented by the Director of Food Safety and Applied Nutrition (FSAN), Mrs. Eva Edwards disclosed that the World Health Organisation (WHO) global target for exclusive breastfeeding is 50 percent by 2025, while the demographic and health survey indicates that only 28.7 percent of nursing mothers embrace exclusive breastfeeding in Nigeria.

She reiterated the need for Nigerian nursing mothers to embrace exclusive breastfeeding of their infants for the first six months of life to improve the health status of their newborns.

She emphasised that NAFDAC remains resolutely committed to implementing and monitoring adherence to the provisions of the Code as the Agency designated by law for this responsibility in the amendment Decree No. 22 – Marketing (Breast-milk Substitutes) of 1999.

Exclusive breastfeeding – defined as the practice of only giving an infant breast milk for the first 6 months of life (no other food or water) – has the single largest potential impact on child mortality of any preventive intervention. It is part of optimal breastfeeding practices, which also include initiation within one hour of life and continued breastfeeding for up to two years of age or beyond.

The NAFDAC boss pointed out that exclusive breastfeeding is the best start in life and the cornerstone of child survival and health because it provides essential, irreplaceable nutrition as nature intended for a child’s optimal growth and development.

Prof Adeyeye, noted that inappropriate marketing of breast-milk substitutes contributes to undermining efforts to improve breastfeeding rates and duration.

According to her, the stakeholders’ engagement with the Association of Infant Food Manufacturers and Marketers in Nigeria (AIFMN) is aimed at fostering fruitful dialogue on the implementation of the International Code of Marketing of Breast-milk Substitutes (the Code) and the National Regulations on the Marketing of Infant and Young Children Food and other Designated Products (Registration, Sales etc).

She explained that the International Code of Marketing of Breast-milk Substitutes, including the subsequent relevant World Health Assembly (WHA) resolutions aim to contribute to the provision of safe and adequate nutrition for infants, by the protection and promotion of breastfeeding, and by ensuring the proper use of breast-milk substitutes, when they are necessary, based on adequate information and through appropriate marketing and distribution.

‘’We cannot overemphasise the significance of breastfeeding in the context of maternal and child health,” she said, adding that recognising the irreplaceable impact of breastfeeding on the health and development of infants and young children all over the world, and for the purpose of the engagement, infants and young children in Nigeria, NAFDAC remains resolutely committed to implementing and monitoring adherence to the provisions of the Code as the Agency designated by law for this responsibility in the amendment Decree No. 22 – Marketing (Breast-milk Substitutes) of 1999.

She further explained that the responsibility for monitoring and enforcing compliance with the provisions of the Code and national regulations covers the spectrum of actors in the infant and young child feeding space (and their actions): these include manufacturers, distributors, marketers, and other stakeholders.

‘’You will recall that the sixty-ninth World Health Assembly, which held in 2016 adopted Resolution WHA69.9 which urged Member States and health professionals to implement the recommendations in the accompanying WHO Guidance on Ending Inappropriate Promotion of Foods for Infants and Young Children,” she said, adding that the Guidance seeks to ensure that financial support for infant and young child health programmes and workers do not create conflicts of interest (COI).

It states that “companies that market foods for infants and young children should not sponsor meetings of health professionals and scientific meetings and that health workers, health systems, and health professional associations should not allow such sponsorship.”

Prof. Adeyeye further stated that the Guidance also notes that health professionals and facilities are often targeted and influenced by the infant and young child food industry through promotion, relationships, and incentives, and that these incentives create conflicts of interest and can result in the loss of independence, integrity, and public credibility.

She said a conflict of interest arises every time anyone (including a non-professional health worker or health educator) whose duty it is to promote breastfeeding accepts some kind of gift or benefit from a company.

‘’Last year, the WHO, together with a Technical Advisory Group (TAG), in recognition of the current trend of digital promotion of BMS, developed the guidance on digital marketing technologies to address these new marketing tools that are powerfully persuasive and often easily recognizable as breast-milk substitute promotions,” she said, adding that digital marketing can indeed deliver breast-milk substitutes promotions covertly.

As regulators, she said “we welcome the development of the guidance document, having dealt with issues of digital promotions of breast-milk substitutes.”

As manufacturers, representatives of manufacturers and marketers, she said, “you are aware of your responsibility to align your practices with the provisions of the BMS Code and national regulations, recognising that inappropriate promotions have a significant impact on infant health, nutrition, and development.”

She said the Agency is fully committed to protecting and promoting breastfeeding to address threats that marketing of breastmilk substitutes (BMS) pose to optimal breastfeeding practices.

She noted that the engagement of stakeholders presented a platform for open dialogue, to increase knowledge on the Code, share insights, experiences, and challenges on implementing the Code in Nigeria, adding that “your collaboration and adherence to the BMS Code are instrumental in creating a conducive environment for optimal infant breastfeeding feeding practices and ensuring the wellbeing of future generations of healthy and productive Nigerians.”

She reminded them that breast-milk substitutes are legitimate products which should be available for use when they are necessary, based on adequate information and through appropriate marketing and distribution.

“Our concern is strictly on inappropriate marketing practices. In the spirit of creating a conducive environment where the health and well-being of mothers and infants are prioritized, I wish us a fruitful and interactive session,” she said.

Health

Assembly passes Kano Pre-Marital Health Screening Bill

Published

on

Kano State House of Assembly has passed a bill for a law to compel intending couples to undergo HIV, hepatitis and sickle cell anaemia screening before marriage.

The passage followed deliberations in the Committee of the Whole House during plenary session,
presided over by the Speaker, Ismail Falgore on Monday in Kano.

After deliberations, the lawmakers approved the 3rd reading of the bill, read by the Deputy Clerk, Alhaji Nasiru Magaji.

Shortly after passage of the bill, the Majority Leader of the house, Lawan Hussein (NNPP-Dala), stated that “any person
intending to marry shall first submit self for medical examinations.”

He said the bill was considered and passed after the 3rd reading, following various legislative processes.

The leader further said that the bill was passed because the state had been battling with different health issues, including
HIV because people go into marriages without medical screening.

He said that the bill, if signed into law, would save many lives and curb the spread of life-threatening diseases.

“The bill will safeguard the health of citizens by institutionalising pre-marital testing to check the spread of diseases
like hepatitis, HIV and sickle cell anaemia,” he added.

Continue Reading

Health

WHO to begin vaccination against Human Papilloma Virus May 27 in Kogi

Published

on

The World Health Organisation (WHO), says it plans to commence vaccination against Human Papilloma Virus (HPV) on May 27 in Kogi.

The state’s Team Lead of WHO, Dr Muktar Toyosi, said this when he led his team on an advocacy visit to the State Council of the Nigeria Union of Journalists (NUJ) on Wednesday in Lokoja.

Toyosi said that the vaccination was meant for girl child of between the age nine and 14.

He said the ongoing sensitisation was to keep the people informed, and educate them on the vaccination of their children to protect them against cervical cancer in future.

”Kogi falls within the second phase of the programme. We are soliciting for the cooperation of the media in educating the people of the state on the HPV vaccination.

“There need for girls child across the state to take the vaccination to safeguard their future.

“Although the vaccine was initially scarce and difficult to get, the good news now is that it has been made available by the government,” Toyosi said.

Also speaking, the State Technical Assistant for WHO, Dr Ahmed Attah, said that the HPV mostly affect women, adding that the vaccination remained a preventive measure against the disease.

Attah, a former state Chairman of the Nigeria Medical Association (NMA) and a former Chief Medical Director (CMD), Kogi Specialist Hospital (KSSH) Lokoja, urged parents and guardians to avail their children of the vaccination to justify government’s investment.

In his response, the Kogi NUJ Chairman, Mr Seidu Ademu, described the health sector as very critical, stressing that the vaccination was a right step in the right direction.

Ademu promised a robust partnership with WHO to enable the team to achieve its set goals.
He stressed the need to inform, educate and sensitise the general public on the need to embrace the vaccine by ensuring that girls within the age range were vaccinated.

Continue Reading

Health

NCDs will be leading cause of mortality in Africa by 2030 – WHO

Published

on

The World Health Organisation (WHO) says Non-communicable Diseases (NCDs) will become the leading cause of mortality in Africa by 2030 if urgent measures are not executed by member states.

Dr Matshidiso Moeti, WHO Regional Director for Africa, joining virtually, made the assertion on Tuesday at the opening of the first International Conference on PEN-Plus in Africa (ICPPA 2024) in Dar es Salaam, Tanzania.

The ICPPA 2024, holding from April 23 to April 25, is aimed at addressing severe NCDs in Africa.

It is being hosted by the WHO Regional Office for Africa, Helmsley Charitable Trust, and the United Republic of Tanzania. Moeti urged member states to embrace strategies that would help to address the issue.

“We are faced with non-communicable diseases and data from low and middle income countries show that 26 per cent of total health spending was due to NCDs, second only to infectious and parasitic diseases.

“Meaning it is urgent to give these often overlooked diseases priority attention as Africa is severely affected and more than in any other place in the world.

“The surge in the burden of NCDs on our continent over the past two decades, is driven by increasing incidences of risk factors, such as unhealthy diets, reduced physical activity, obesity, and air pollution.

“NCDs are set to overtake communicable, maternal, neonatal and nutritional diseases combined as a leading cause of mortality in Africa by 2030.

“And here, the NCDs are called silent epidemics. Unfortunately, this rapid devolution, with a higher mortality rate has not been recognised in the region, because we’re not investing adequately in detecting and lowering the burden of these diseases,” Moeti said.

Moeti noted that severe NCDs like type one diabetes, rheumatic heart disease, and sickle cell disease more frequently affect children and young adults in the majority of Africans population.

She advised that Africa must show increased commitment in addressing NCDs with adequate and sustained resources.

She also said there was the need to strengthen accountability and assess the impact of interventions by enhancing surveillance and monitoring.

According to Moeti, this can be achieved using reliable and timely data at national and sub national levels to drive policy and action as we move forward.

Ms Elke Wisch, UNICEF Representative to Republic of Tanzania, said that collaboration was at the heart of collective response to tackling NCDs.

“Today’s gathering underscores the urgency and importance of addressing NCDs comprehensively and collaboratively.

“The WHO package of essential non communicable  interventions for PEN, for primary healthcare and low resources settings, and the recently launched regional strategy on PEN-Plus provides a strategic framework  for tackling NCDs at their roots,” she said.

Also speaking, Ummy Mwalimu, Minister of Health, Tanzania, said that non communicable diseases NCDs, have become a formidable threat to the health and wellbeing of “our people.”

She urged for collective efforts to address these threats.

“They are silently affecting the lives of our citizens, our communities, undermining the progress we strive to achieve as a nation.

“The impact of these diseases extends beyond individual suffering.

“It affects our communities, our economy, and ultimately the future of our nations in our continent.

“Yet, in the face of these challenges, we are not discouraged together. We have chosen to confront these non-communicable diseases.’’

She urged for lifestyle change as positive way to combatting the negative outcomes of NCDs.

James Reid, Programme Officer for the Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Programme, said he was happy at the level of interest and momentum in engagements to address NCDs, especially Type 2 diabetes.

He, however, identified finance as one of the biggest challenge and hindrance. He said that while political leaders and stakeholders identify the challenges that NCDs pose, the strategies to prevent them, especially NCD care, were limited.

“Leadership for driving of PEN-Plus is very important to make sure that ministry of health leaders and all others involved, really understand how to change the dynamics as well as adopt solutions to suit specific localities,” she said.

WHO’s PEN-Plus (Package of Essential NCD-Plus), is a regional integrated care delivery strategy to address severe non-communicable diseases at first-level referral health facilities.

At the 2022 WHO Regional Committee Meeting for the African Region, the 47 Member States of the AFRO region voted to adopt the PEN-Plus strategy.

It is focused on alleviating the burden among the poorest children and young adults. This is by increasing the accessibility and quality of chronic care services for severe NCDs including Type 1 diabetes, rheumatic heart disease, and sickle cell disease.

 ICPPA 2024 provides opportunity to shore up international support for scaling up PEN-Plus in the African Region. Also, the conference serves as a platform to raise awareness of severe NCDs, share lessons from countries implementing PEN-Plus and identify opportunities to strengthen NCD management.

Continue Reading

Trending